Cost-effectiveness Analysis: Clinical Trials

6 trials for Cost-effectiveness Analysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 recruiting, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 31Unknown 1

Follow Cost-effectiveness Analysis: new trials by email Literature Review of Cost-effectiveness Analysis trials Research Report on Cost-effectiveness Analysis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
throMboembolic Risk Associated To High atrIal Fibrillation riSk
AI_MATHIAS - MACE, Atrial Fibrillation (AF)
Not yet recruitingFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina10002026-07-062026-03-02
The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
AI-ECG P4P program - OMI - Occlusion Myocardial Infarction, Artificial Intelligence (AI)
Not applicableRecruitingNational Defense Medical Center, Taiwan2120002025-08-012026-04-09
Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K
Myopia, Cost-effectiveness Analysis
RecruitingHe Eye Hospital902023-11-102026-03-23
Cost-effectiveness Analysis of an Antimicrobial Stewardship Program in Regione Lombardia (RF-net2018)
Antimicrobial Stewardship, Cost-effectiveness Analysis
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico500002023-03-012024-04-29
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
Long-acting granulocyte colony stimulating factor, Short-acting granulocyte colony stimulating factor - Chemotherapy-induced Neutropenia, Febrile Neutropenia, Drug-Induced
Phase 3UnknownLei Li2002019-10-012019-10-08
Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis
Cost-effectiveness Analysis, Chronic Kidney Disease Requiring Chronic Dialysis
UnknownUniversidade Estadual Paulista Júlio de Mesquita Filho1982017-04-012019-10-02

Narrower conditions

Atrial Fibrillation (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Chemotherapy-Induced Febrile Neutropenia (1)  ·  Myopia (1)  ·  Stroke (1)

Broader conditions

Adnexal Diseases (1)  ·  Agranulocytosis (1)  ·  Arrhythmias, Cardiac (1)  ·  Brain Diseases (1)  ·  Carcinoma (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cytopenia (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Eye Diseases (1)  ·  Febrile Neutropenia (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  He Eye Hospital (1)  ·  Lei Li (1)  ·  National Defense Medical Center, Taiwan (1)  ·  Universidade Estadual Paulista Júlio de Mesquita Filho (1)

Countries

China (2)  ·  Brazil (1)  ·  Italy (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Andrea Gori (1)  ·  Chin Lin, PhD (1)  ·  Josep Clua-Espuny, PhD (1)  ·  Lei Li, M.D. (1)

Results publications

PMID 33320346, PMID 33501650, PMID 33546615, PMID 35998199, PMID 38373864, PMID 39857703